...
首页> 外文期刊>Clinical Genetics: An International Journal of Genetics in Medicine >Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis
【24h】

Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis

机译:使用单染色体双探针FISH分析检测从母体血液分离的胎儿细胞中的染色体非整倍体

获取原文
获取原文并翻译 | 示例
           

摘要

Detection of chromosomal aneuploidies using fetal cells isolated from maternal blood, for prenatal non-invasive genetic investigation, has been a long-sought goal of clinical genetics to replace amniocentesis and chorionic villous sampling to avoid any risk to the fetus. The purpose of this study was to develop a sensitive and specific new assay for diagnosing aneuploidy with circulating fetal cells isolated from maternal blood as previously reported using two novel approaches: (i) simultaneous immunocytochemistry (ICC) evaluation using a monoclonal antibody for i-antigen, followed by fluorescence in situ hybridization (FISH); (ii) dual-probe FISH analysis of interphase nuclei using two differently labeled probes, specific for different loci of chromosomes 21 and 18; in addition, short tandem repeats (STR) analysis on single cells isolated by micromanipulation was applied to confirm the presence of fetal cells in the cell sample enriched from maternal blood. Blood samples were obtained from women carrying trisomic fetuses, and from non-pregnant women and men as controls. Using ICC-FISH approach, a large heterogeneity in immunostaining pattern was observed, which is a source of very subjective signal interpretation. Differently, dual-probe FISH analysis provided for a correct diagnosis of all pregnancies: the mean percentage of trisomic cells was 0.5% (range, 0.36-0.76%), while the mean percentage of trisomic cells in the control group (normal pregnancies or non-pregnant women) was ≤0.20%. The application of the dual-probe FISH protocol on fetal cells isolated from maternal blood enables accurate molecular detection of fetal aneuploidy, thus providing a foundation for development of non-invasive prenatal diagnostic testing.
机译:利用产妇血液中分离的胎儿细胞进行染色体非整倍性检测,以进行产前非侵入性遗传研究,一直是临床遗传学长期追求的目标,以取代羊膜腔穿刺术和绒毛膜绒毛取样以免对胎儿造成任何风险。这项研究的目的是开发一种灵敏,特异性的新方法,用于诊断以前从母体血液中分离出来的循环胎儿细胞的非整倍性,这是以前使用两种新颖方法报道的:(i)使用针对i抗原的单克隆抗体进行同时免疫细胞化学(ICC)评估,然后进行荧光原位杂交(FISH); (ii)使用两种不同标记的探针对相间核进行双探针FISH分析,这些探针对21号和18号染色体的不同位点具有特异性;此外,对通过显微操作分离的单个细胞进行了短串联重复序列(STR)分析,以确认在富含母体血液的细胞样品中是否存在胎儿细胞。从携带三体胎儿的妇女以及未怀孕的男女中获取血样。使用ICC-FISH方法,观察到免疫染色模式存在很大的异质性,这是非常主观的信号解释的来源。不同的是,双探针FISH分析可正确诊断所有妊娠:三体细胞的平均百分比为0.5%(范围为0.36-0.76%),而对照组中三体细胞的平均百分比(正常怀孕或非正常怀孕)。 -孕妇)≤0.20%。将双探针FISH方案应用于从母体血液分离的胎儿细胞,可以对胎儿非整倍性进行准确的分子检测,从而为开发非侵入性产前诊断测试奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号